Since then, many studies have focused on understanding the dynamics of HERV-W transcriptional activity in MS, and it is a consensus that HERV-W expression is increased from 1.5 to 3 fold in MS patients compared with healthy controls (100–108). The gene discussed is ERVW-1; the disease is myeloid sarcoma.